J&J and Colgate pay $4.8 million each to woman in California

pharmafile | June 13, 2019 | News story | Business Services, Medical Communications Cancer, J&J, JJ, lawsuit, pharma, talc 

A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a woman who developed cancer.

Colgate and J&J must pay Patricia Schmitz $4.8 million in damages each. The ruling comes after Schmitz developed mesothelioma after using J&J’s Baby Powder and Colgate’s Cashmere Bouquet. Schmitz was not awarded punitive damages.

The ruling comes as another setback for healthcare conglomerate J&J who face more than 13,000 talc-related lawsuits. J&J was just two weeks ago ordered to pay $300 million in punitive damages to a woman in New York who developed cancer after using the firm’s products.

Jurors in South Carolina cleared the company of liability in a different case on the same day.

“We will pursue an appeal because Johnson’s Baby Powder does not contain asbestos or cause cancer, as supported by decades of independent clinical evidence,” a J&J spokesperson said.

“There were serious procedural and evidentiary errors in the proceeding that required us to move for mistrial on multiple occasions and we believe provide strong grounds for appeal.”

Louis Goss

Related Content


Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

Innate Pharma has announced that the drug jointly researched between itself and Sanofi has received US …


GRAIL and University of Oxford showcase first prospective study results for multi-cancer early detection test

US-based healthcare company GRAIL and the University of Oxford, UK, have announced encouraging first prospective …

ISA Pharmaceuticals highlights positive clinical data at ASCO

Clinical stage biotechnology company ISA Pharmaceuticals has announced positive phase 1 data at the American …

Latest content